ALS Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

ALS şirketinin toplam hissedar öz sermayesi A$1.1B ve toplam borcu A$1.6B olup, bu da borç-öz sermaye oranını 142.7% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla A$3.8B ve A$2.7B dir. ALS 'in FAVÖK'ü A$468.4M faiz karşılama oranı 6.4 dur. Şirketin A$254.6M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

142.7%

Borç/özkaynak oranı

AU$1.64b

Borç

Faiz karşılama oranı	6.4x
Nakit	AU$254.60m
Eşitlik	AU$1.15b
Toplam yükümlülükler	AU$2.66b
Toplam varlıklar	AU$3.80b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CP4 'nin kısa vadeli varlıkları ( A$1.0B ) kısa vadeli yükümlülüklerini ( A$713.7M ) aşıyor.

Uzun Vadeli Yükümlülükler: CP4 'un kısa vadeli varlıkları ( A$1.0B ) uzun vadeli yükümlülüklerini ( A$1.9B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CP4 'nin net borç/öz sermaye oranı ( 120.5% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: CP4 şirketinin borç/öz sermaye oranı son 5 yılda 73.8% seviyesinden 142.7% seviyesine yükseldi.

Borç Kapsamı: CP4 'nin borcu işletme nakit akışı ( 22.9% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: CP4 'in borcuna ilişkin faiz ödemeleri EBIT ( 6.4 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

ALS Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Now 21% overvalued

Now 20% overvalued

ALS Limited Appoints Dayna Field as General Counsel and Company Secretary, Effective 1 October 2024

ALS Limited Announces Resignation of Michael Pearson as Company Secretary & General Counsel

ALS Limited to Report Fiscal Year 2025 Results on May 27, 2025

Final dividend of AU$0.039 announced

New minor risk - Earnings quality

Full year 2024 earnings released: EPS: AU$0.027 (vs AU$0.57 in FY 2023)

ALS Limited (ASX:ALQ) agreed to acquire Wessling Holding Gmbh & Co.Kg.

Now 20% undervalued after recent price drop

Now 20% undervalued

ALS Limited, Annual General Meeting, Jul 31, 2024

ALS Limited Appoints Stuart Hutton as Chief Financial Officer, Effective 1 February 2024

Investor sentiment improves as stock rises 19%

ALS Limited Announces Stepdown of Luis Damasceno as Chief Financial Officer, Effective 19 January 2024

ALS Limited Appoints Heike Truöl as Chief Strategy Officer

ALS Limited to Report Fiscal Year 2024 Results on May 21, 2024

Independent Chairman recently bought €364k worth of stock

ALS Limited Announces Board Changes

Upcoming dividend of AU$0.19 per share at 3.4% yield

ALS Limited Declares Final Dividend for the Fiscal Year 2023, Payable on 6 July 2023

Full year 2023 earnings released: EPS: AU$0.57 (vs AU$0.39 in FY 2022)

ALS Limited Appoints Malcolm Deane as Managing Director

Insufficient new directors

Upcoming dividend of AU$0.20 per share

First half 2023 earnings released: EPS: AU$0.30 (vs AU$0.15 in 1H 2022)

ALS Limited Declares an Unfranked Interim Dividend for the First Half of Fiscal Year 2023, Payable on 16 December 2022

ALS Limited Appoints Peter Possemiers as an Independent Non-Executive Director Effective 1 November 2022

ALS Limited Declares Final Dividend

ALS Limited (ASX:ALQ) announces an Equity Buyback for 9,000,000 shares, representing 1.86% for AUD 100 million.

ALS Limited to Report Fiscal Year 2023 Results on May 24, 2023

ALS Limited (ASX:ALQ) made an non-binding indicative offer to acquire HRL Holdings Limited (ASX:HRL) for AUD 79 million.

ALS Limited (ASX:ALQ) made an non-binding indicative offer to acquire HRL Holdings Limited (ASX:HRL) for AUD 79 million.

Independent Non-Executive Director recently bought €59k worth of stock

Independent Non-Executive Director recently bought €59k worth of stock

Upcoming dividend of AU$0.17 per share

Full year 2022 earnings released: EPS: AU$0.40 (vs AU$0.36 in FY 2021)

ALS Limited Declares Dividend for the Period Ended March 31, 2022, Payable on July 4, 2022

ALS Limited Declares Dividend for the Period Ended March 31, 2022, Payable on July 4, 2022

ALS Limited to Report First Half, 2023 Results on Nov 14, 2022

Insufficient new directors

Investor sentiment improved over the past week

Insufficient new directors

ALS Limited (ASX:ALQ) agreed to acquire MinAnalytical Laboratory Services Pty Ltd. from Perenti Global Limited (ASX:PRN) for AUD 39 million.

Upcoming dividend of AU$0.16 per share

First half 2022 earnings released: EPS AU$0.15 (vs AU$0.14 in 1H 2021)

Independent Non-Executive Director recently bought €73k worth of stock

Investor sentiment improved over the past week

Upcoming dividend of AU$0.15 per share

Full year 2021 earnings released: EPS AU$0.36 (vs AU$0.16 in FY 2020)

ALS Limited Declares Final Dividend, payable on July 5, 2021

ALS Limited (ASX:ALQ) entered in an agreement to acquire Investiga.

New 90-day high: €6.90

New 90-day high: €6.45

ALS Limited to Report Fiscal Year 2021 Final Results on Jun 23, 2021

First half 2021 earnings released: EPS AU$0.15

ALS Limited, Annual General Meeting, Jul 28, 2021

Revenue misses expectations

ALS Limited to Report Fiscal Year 2021 Results on May 26, 2021

New 90-day high: €6.00

New 90-day high: €5.80

New 90-day high: €5.75

New 90-day high - €5.50

New 90-day high - €5.40

New 90-day high - €4.58

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin